EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Proteomic Profiling Uncovers LGALS3BP as a Potential Biomarker for Idiopathic Pulmonary Arterial Hypertension

Mingfei Li, Qi Jin iD, Wenzhi Pan iD, Dan Tian iD, Peng Wang, Dandan Chen, Yuan Zhang, Shasha Chen, Daxin Zhou iD, Lihua Guan iD, Junbo Ge

The Clinical Respiratory Journal · 2025-12 · 19 (12)

DOI: 10.1111/crj.70138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 27.11.2025. Verfasst von Mingfei Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China. Hauptthemen laut MEDLINE: Familial Primary Pulmonary Hypertension, Antigens, Neoplasm, Extracellular Matrix Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Top Priority Research Center Construction Project, Yangfan Project of the Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Idiopathic pulmonary arterial hypertension (IPAH) is a progressive and fatal disease characterized by pathological pulmonary vascular remodeling and right heart failure. Current biomarkers for IPAH demonstrate limited clinical utility, necessitating the discovery of noninvasive serum biomarkers to facilitate early diagnosis and prognosis.

Objective

To identify novel serum biomarkers for IPAH using tandem mass tag–based quantitative proteomics and validate their clinical relevance.

Methods

Serum samples from five IPAH patients and five age/sex‐matched healthy controls (discovery cohort) were analyzed by tandem mass tag proteomics to screen differentially expressed proteins (DEPs). Functional enrichment and protein–protein interaction network analyses were performed. Serum galectin‐3 binding protein (LGALS3BP) levels were validated by enzyme‐linked immunosorbent assay (ELISA) in an expanded cohort (30 IPAH patients vs. 30 controls).

Results

Proteomic analysis identified 401 proteins and 1554 peptide fragments, with 114 DEPs between groups (47 up‐regulated and 67 down‐regulated). In biological processes, DEPs are primarily enriched in adaptive immune response, followed by signal transduction. Extracellular exosome and extracellular region are the most commonly enriched cell components. For molecular function, DEPs are mainly involved in antigen binding and calcium ion binding, with the top 30 Gene Ontology terms exhibiting similar distribution patterns between up‐ and down‐regulated DEPs. Pathway analysis revealed significant enrichment in complement/coagulation cascades, immune response, and extracellular matrix remodeling. LGALS3BP was observed to be significantly up‐regulated in IPAH serum compared with controls (fold change = 1.36, p < 0.001), a finding validated by independent ELISA (IPAH: 6.43 ± 1.73 μg/mL vs. controls: 2.33 ± 1.06 μg/mL; p < 0.001).

Conclusions

Integrated proteomic profiling and clinical validation provide the first evidence of elevated serum LGALS3BP in IPAH, indicating its putative role in pathogenesis and translational medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Familial Primary Pulmonary HypertensionAntigens, NeoplasmExtracellular Matrix ProteinsBiomarkersProteomeCarrier ProteinsEnzyme-Linked Immunospot AssayProtein Interaction MapsProteomicsTandem Mass SpectrometryHumansMaleFemaleAdultMiddle Aged

Stichwörter der Autor:innen

LGALS3BPidiopathic pulmonary arterial hypertensionproteomicsserum biomarker

Substanzen

BiomarkersProteomeCarrier ProteinsLGALS3BP protein, humanAntigens, NeoplasmExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
  • State key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
  • National Clinical Research Center for Interventional Medicine, Shanghai, China.
  • Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Qi Jin, Wenzhi Pan, Dan Tian, Daxin Zhou, Lihua Guan

Förderung

  • National Natural Science Foundation of China
  • Shanghai Top Priority Research Center Construction Project
  • Yangfan Project of the Science and Technology Commission of Shanghai Municipality
  • Youth Fund of Zhongshan Hospital, Fudan University

Zitieren

APA

Li, M., Jin, Q., Pan, W., Tian, D., Wang, P., Chen, D., Zhang, Y., Chen, S., Zhou, D., Guan, L., & Ge, J. (2025). Serum Proteomic Profiling Uncovers LGALS3BP as a Potential Biomarker for Idiopathic Pulmonary Arterial Hypertension. The Clinical Respiratory Journal, 19(12). https://doi.org/10.1111/crj.70138

Vancouver

Li M, Jin Q, Pan W, Tian D, Wang P, Chen D, et al. Serum Proteomic Profiling Uncovers LGALS3BP as a Potential Biomarker for Idiopathic Pulmonary Arterial Hypertension. The Clinical Respiratory Journal. 2025;19(12). doi:10.1111/crj.70138

BibTeX
@article{Li2025,
  author = {Li, Mingfei and Jin, Qi and Pan, Wenzhi and Tian, Dan and Wang, Peng and Chen, Dandan and Zhang, Yuan and Chen, Shasha and Zhou, Daxin and Guan, Lihua and Ge, Junbo},
  title = {Serum Proteomic Profiling Uncovers LGALS3BP as a Potential Biomarker for Idiopathic Pulmonary Arterial Hypertension},
  journal = {The Clinical Respiratory Journal},
  year = {2025},
  volume = {19},
  number = {12},
  doi = {10.1111/crj.70138}
}
Kostenlos starten →